| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Experimental Immunology Branch and
Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
4 Kawamura, T., M. Qalbani, J. M. Orenstein, and A. Blauvelt. 1999. Human mono-cyte-derived dendritic cells propogated in the presence of GM-CSF, IL-4, and TGF-ß1 morphologically, phenotypically, and functionally resemble resident epidermal Langerhans cells Submitted for publication.
The invariant chain (Ii) plays a critical role in the transport of newly synthesized class II molecules to endosomal Ag-processing compartments. Of the two major isoforms of human Ii, only Ii-p35 is phosphorylated in vivo, and inhibiting Ii phosphorylation inhibits the trafficking of newly synthesized class II molecules to Ag-processing compartments. We now report that a member of the protein kinase C family of serine/threonine kinases is responsible for the constitutive phosphorylation of 50% of the total cellular pool of Ii-p35 in a wide variety of APCs, including B lymphocytes, PBMC, immature dendritic cells, and mature dendritic cells. Stimulation of protein kinase C activity in APCs significantly enhanced the kinetics of degradation of class II-associated Ii in Ag-processing compartments and the binding of antigenic peptides to these class II molecules. In cells expressing an Ii-phosphorylation mutant, trafficking of class II molecules to endosomes was impaired and Ii proteolysis was inhibited, demonstrating a direct effect of Ii phosphorylation on MHC class II trafficking. These results demonstrate that phosphorylation of Ii in APCs alters the kinetics of trafficking of newly synthesized class II molecules to lysosomal Ag-processing compartments.
This article has been cited by other articles:
|
|
 |
|
  S. Sun, E. W P Wong, M. W M Li, W. M Lee, and C Y. Cheng 14-3-3 and its binding partners are regulators of protein-protein interactions during spermatogenesis J. Endocrinol., September 1, 2009; 202(3): 327 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Szaszak, H.-D. Chen, H.-C. Chen, A. Baukal, L. Hunyady, and K. J Catt Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein J. Endocrinol., November 1, 2008; 199(2): 165 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Majewski, T. O. Bose, F. C. M. Sille, A. M. Pollington, E. Fiebiger, and M. Boes Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells Int. Immunol., June 1, 2007; 19(6): 719 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Yoo, L. Fang, A. Mason, B.-Y. Kim, and P. A. Welling A Phosphorylation-dependent Export Structure in ROMK (Kir 1.1) Channel Overrides an Endoplasmic Reticulum Localization Signal J. Biol. Chem., October 21, 2005; 280(42): 35281 - 35289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Khalil, A. Brunet, and J. Thibodeau A three-amino-acid-long HLA-DR{beta} cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35 J. Cell Sci., October 15, 2005; 118(20): 4679 - 4687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Khalil, A. Brunet, I. Saba, R. Terra, R. P. Sekaly, and J. Thibodeau The MHC class II {beta} chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal Int. Immunol., October 1, 2003; 15(10): 1249 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yan, L. Shi, A. Penfornis, and D. L. Faustman Impaired Processing and Presentation by MHC Class II Proteins in Human Diabetic Cells J. Immunol., January 1, 2003; 170(1): 620 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. McCarthy, M Lam, L Subramanian, R Shakya, Z Wu, E. Newton, and N. Simister Effects of mutations in potential phosphorylation sites on transcytosis of FcRn J. Cell Sci., January 4, 2001; 114(8): 1591 - 1598. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
